Cita APA (7a ed.)

Meijer, A. J. M., Diepstraten, F. A., Langer, T., Broer, L., Domingo, I. K., Clemens, E., . . . Consortium, a. t. C. (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. Nature Portfolio.

Cita Chicago Style (17a ed.)

Meijer, A. J. M., et al. TCERG1L Allelic Variation Is Associated with Cisplatin-induced Hearing Loss in Childhood Cancer, a PanCareLIFE Study. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Meijer, A. J. M., et al. TCERG1L Allelic Variation Is Associated with Cisplatin-induced Hearing Loss in Childhood Cancer, a PanCareLIFE Study. Nature Portfolio, 2021.